FINWIRES · TerminalLIVE
FINWIRES

$PGNY

7 stories mentioning PGNYUpdated 6d ago

Every FINWIRES story that references PGNY, newest first.

What are analysts saying about PGNY?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on PGNY?

Insider Trading

Progyny Insider Sold Shares Worth $321,358, According to a Recent SEC Filing

Kevin K Gordon, Director, on September 10, 2026, sold 11,500 shares in Progyny (PGNY) for $321,358. Following the Form 4 filing with the SEC, Gordon has control over a total of 6,792 common shares of the company, with 6,792 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1551306/000155130626000152/xslF345X05/wk-form4_1789422827.xml

$PGNY
Research

Wells Fargo Initiates Progyny at Overweight With $37 Price Target

Progyny (PGNY) has an average rating of buy and mean price target of $34, according to analysts polled by FactSet.

$PGNY
Wire

Progyny Shares Drop After Downgrade From Barclays

Progyny (PGNY) shares were down 2.5% in afternoon trading on Tuesday after Barclays downgraded the company's stock to equal-weight from overweight, and adjusted the price target to $34 from $27.Trading volume stood at more than 950,000 shares against a daily average of about 1.5 million.Price: $30.71, Change: $-0.88, Percent Change: -2.79%

$PGNY
Research

Barclays Downgrades Progyny to Equalweight From Overweight, Adjusts Price Target to $34 From $27

Progyny (PGNY) has an average rating of buy and mean price target of $34, according to analysts polled by FactSet.

$PGNY
Wire

Progyny Approves Up to $200 Million Stock Buyback Plan

Progyny (PGNY) board authorized a stock buyback plan worth up to $200 million of its common shares, the company said Tuesday.The buyback plan will be financed using the company's available cash resources, Progyny added.Price: $25.37, Change: $+0.48, Percent Change: +1.95%

$PGNY
Research

Canaccord Genuity Upgrades Progyny to Buy From Hold, Adjusts PT to $30 From $19

Progyny (PGNY) has an average rating of Buy and mean price target of $29.55, according to analysts polled by FactSet.

$PGNY
Wire

Progyny Launches Supplemental Fertility Benefit Plan For Small Employers

Progyny (PGNY) said Thursday it released a fully insured supplemental fertility and family building plan for small U.S. employers.The medical benefit platform uses a fixed per-employee-per-month pricing model to help establish predictable healthcare costs for smaller corporate clients, the company said.The offering provides support across fertility and women's health, including IVF, IUI, genetic testing, and coaching for pregnancy, postpartum, parenting, and menopause, Progyny said.The plan will be available for employers to implement in their 2027 plan years.Price: $17.63, Change: $+0.24, Percent Change: +1.38%

$PGNY

Track with the FINWIRES app suite